Published in:
01-05-2015 | Erratum
Erratum to: Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy
Published in: Medical Oncology | Issue 5/2015
Login to get accessExcerpt
The original version of this article unfortunately contained a mistake. Table 3 was published with incorrect values. The corrected Table 3 is given below. The authors regret the inconvenience caused to the readers in this regard.
Table 3
Treatment history after brain metastases diagnosis
|
Treatment
|
EGFR mutation status
|
p value
|
|
|---|---|---|---|
|
EGFR mutant (89)
|
Wild-type (108)
|
||
|
Brain metastasectomy
|
|||
|
Yes/no
|
5/84
|
5/103
|
0.76
|
|
Radiotherapy
|
|||
|
Yes/no
|
57/32
|
87/21
|
0.010*
|
|
WBRT
|
21
|
28
|
|
|
Radiosurgery
|
28
|
43
|
|
|
Both WBRT and radiosurgery
|
8
|
16
|
|
|
EGFR-TKIs
|
|||
|
Yes/no
|
66/23
|
26/82
|
<0.0001*
|
|
Gefitinib
|
34
|
8
|
|
|
Erlotinib
|
12
|
15
|
|
|
Both gefitinib and erlotinib
|
20
|
3
|
|